Market Overview

Adeptus Health Inc. Investigated For Securities Fraud By Block & Leviton After Delaying Its Year-End Financial Results


BOSTON, March 2, 2017 /PRNewswire/ -- Block & Leviton LLP (, a securities litigation firm representing investors nationwide, is investigating whether Adeptus Health Inc. ("Adeptus" or the "Company") (NYSE: ADPT) and certain of its officers and directors violated federal securities laws following the Company's announcement that it will not timely file it's 2016 financial results due to "material weaknesses" in its financial reporting.

On March 2, 2017, Adeptus' stock plunged nearly 60% on the Company's announcement that it is not able to timely file its full year 2016 financial results, citing "material weaknesses with respect to internal control over financial reporting of revenue recognition, accounts receivable, accounting for a contribution to an unconsolidated joint venture, and accounting for equity in (loss) earnings of unconsolidated joint ventures." Adeptus went on to say that the Company has "substantial doubt" about its ability to continue as a going concern absent securing committed long-term financing. 

If you purchased or otherwise acquired Adeptus securities and have questions about your legal rights or possess information relevant to this investigation, please contact attorney Bradley Vettraino at (617) 398-5600, by email at, or by visiting

Confidentiality to whistleblowers or others with information relevant to this investigation is assured.

Block & Leviton LLP is a Boston-based law firm representing investors nationwide. The firm's lawyers have collectively been prosecuting securities cases on behalf of individual and institutional investors for over 50 years, and have recovered billions of dollars on their behalf. Block & Leviton's investigations into corporate wrongdoing were recently covered by the New York Times.

This notice may constitute attorney advertising.


Block & Leviton LLP
Bradley J. Vettraino
155 Federal Street, Suite 400
Boston, MA 02110
(617) 398-5600


To view the original version on PR Newswire, visit:

SOURCE Block & Leviton LLP

View Comments and Join the Discussion!